Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NRX Pharmaceuticals (NRXP) Operating Margin (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed Operating Margin for 2 consecutive years, with 470.4% as the latest value for Q4 2025.

  • Quarterly Operating Margin changed N/A to 470.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1324.49% through Dec 2025, down 936884.0% year-over-year, with the annual reading at 1324.41% for FY2025, N/A changed from the prior year.
  • Operating Margin for Q4 2025 was 470.4% at NRX Pharmaceuticals, up from 1662.81% in the prior quarter.
  • The five-year high for Operating Margin was 2607.83% in Q1 2024, with the low at 1662.81% in Q3 2025.